Blood Transfusion in Severe Dengue Infection Blood Transfusion in Severe Dengue Infection
This case series suggests that in many cases of severe dengue infection refractory to standard treatment, blood transfusion may produce rapid improvement, even in patients without bleeding.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 31, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Firearms and blood transfusion: an inescapable disentanglement - Jacobs JW, Stephens LD, Woo JS, Allen ES, Booth GS.
The incidence of mass shootings in the USA continues to increase; more than 45  000 total gun deaths occurred in 2020 alone, the most on record for years with full data available. These statistics highlight increasing gun violence, one of the primary cont... (Source: SafetyLit)
Source: SafetyLit - March 25, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Blood disorder startup Hemab Therapeutics raises $135M
Benny Sorensen remembers the days when, for patients with disorders that caused them to bleed with little provocation, "we had absolutely nothing to give them aside from old-fashioned blood transfusions." Now, he's hoping to change that with a new startup. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 21, 2023 Category: American Health Authors: Rowan Walrath Source Type: news

FDA Moves to Ease Rules for Blood Donations from Gay Men
WASHINGTON — The U.S. is moving to further ease restrictions on blood donations from gay and bisexual men and other groups that typically face higher risks of HIV. The Food and Drug Administration on Friday announced draft guidelines that would do away with the current three-month abstinence requirement for donations from men who have sex with men. Instead, all potential donors would be screened with a new questionnaire that evaluates their individual risks for HIV based on sexual behavior, recent partners, and other factors. If finalized, many gay and bisexual men in monogamous relationships would be able to donate ...
Source: TIME: Health - January 27, 2023 Category: Consumer Health News Authors: Matthew Perrone/AP Tags: Uncategorized healthscienceclimate Public Health wire Source Type: news

Smaller Blood Draws Reduce Transfusions in ICU, Trial Suggests
(MedPage Today) -- SAN FRANCISCO -- Switching to routine use of small-volume blood draws in adult intensive care units (ICUs) for most laboratory testing appeared to cut blood transfusions without compromising those tests, a cluster randomized... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 24, 2023 Category: American Health Source Type: news

Namibia: Only 1 Percent of Namibians Donate Blood
[Namibian] THE Blood Transfusion Service of Namibia (NamBTS) says only 1% of the Namibian population donates blood annually. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 9, 2023 Category: African Health Source Type: news

Consumer Health: What do you know about blood donation?
January is National Blood Donor Month, which makes this a good time to learn more about blood types and the need for blood donation. Nearly 16 million blood components are transfused each year in the U.S., according to the American Red Cross. Daily needs include 29,000 units of red blood cells, 5,000 units of platelets and 6,500 units of plasma. People need a blood transfusion for many reasons. Some may need blood during surgery. Others depend on it after an… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 9, 2023 Category: Databases & Libraries Source Type: news

Eleven science stories likely to make big news in 2023
As the COVID-19 pandemic enters its fourth year as a global health emergency, researchers will continue pushing to help make the disease manageable and ordinary. They will track hundreds of subvariants of Omicron, the highly transmissible but seemingly less lethal strain of SARSCoV-2 that dominated in 2022. Virologists will watch the virus’ evolution this year to see whether it has finally slowed or a more dangerous variant pops up, evading much of the immunity that humanity has built up to previous ones. Vaccine researchers hope to develop new shots that provide broad protection against a variety of coronaviruses.  Ano...
Source: ScienceNOW - January 4, 2023 Category: Science Source Type: news

Cambridge University Researchers Develop and Administer Lab-developed Red Blood Cells in Clinical Study with Promising Results for the Blood Supply
Sickle cell patients and others who need long-term blood transfusions provided by clinical laboratories and others would benefit most from successfully lab-grown blood Administering lab-developed red blood cells in humans in a clinical study conducted in the United Kingdom (UK) is being hailed as a significant step forward in efforts to supplement the supply of […] The post <strong>Cambridge University Researchers Develop and Administer Lab-developed Red Blood Cells in Clinical Study with Promising Results for the Blood Supply</strong> appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - December 19, 2022 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Instruments & Laboratory Equipment Laboratory Pathology Laboratory Resources anatomic pathology Ashley Toye PhD BBC News blood bank Cambridge Clinical Research Facility Cambridge University Hospit Source Type: news

Air ambulances in "whole blood" trial to save more trauma patients
AIR ambulance crews will start giving whole blood transfusions in an effort to save more trauma patients suffering major blood loss. (Source: Daily Express - Health)
Source: Daily Express - Health - December 14, 2022 Category: Consumer Health News Source Type: news

Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX ® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
NEW ORLEANS, December 12, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (D-Rd), evaluating progression-free survival (PFS), minimal residual disease (MRD) negativity and overall response rate (ORR) at a median follow-up of 64.5 months, and overall survival (OS) at a median follow-up of 73.6 months in newly diagnosed, transplant-ineligible (TIE) patients with multiple myeloma, regardless of patients’ age and across clinically important subgroups, as well as health...
Source: Johnson and Johnson - December 12, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

Roche ’s subcutaneous crovalimab given every four weeks achieves disease control in people with PNH, a life-threatening blood condition
The phase III COMMODORE 3 study ofcrovalimab met primary endpoints of transfusion avoidance andhaemolysis control in people with paroxysmal nocturnal hemoglobinuria (PNH)1COMMODORE 3 is the first China-specific study in PNH. Current treatment options are extremely limited in China, resulting in significant levels of disease-related morbidity and mortality for people living with PNH2Based on these datacrovalimab has received Breakthrough Therapy Designation and is under Priority Review for approval in ChinaBasel, 11 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive new data from the phase III COMMO...
Source: Roche Media News - December 11, 2022 Category: Pharmaceuticals Source Type: news

Roche ’s subcutaneous crovalimab given every four weeks achieves disease control in people with PNH, a life-threatening blood condition
The phase III COMMODORE 3 study ofcrovalimab met primary endpoints of transfusion avoidance andhaemolysis control in people with paroxysmal nocturnal hemoglobinuria (PNH)1COMMODORE 3 is the first China-specific study in PNH. Current treatment options are extremely limited in China, resulting in significant levels of disease-related morbidity and mortality for people living with PNH2Based on these datacrovalimab has received Breakthrough Therapy Designation and is under Priority Review for approval in ChinaBasel, 11 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive new data from the phase III COMMO...
Source: Roche Investor Update - December 11, 2022 Category: Pharmaceuticals Source Type: news

Janssen Presents First Data from MajesTEC-2 Trial of TECVAYLI ™ (teclistamab-cqyv) in Combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and Lenalidomide in Relapsed or Refractory Multiple Myeloma
NEW ORLEANS, December 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from a cohort of the Phase 1b MajesTEC-2 study of TECVAYLI™ (teclistamab-cqyv), a first-in-class, BCMAxCD3 bispecific T-cell engager antibody, in combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and lenalidomide. According to the results, the immune-based triplet therapy regimen had a manageable safety profile with no unexpected safety signals observed. A very good partial response (VGPR) or better was achieved by 90.3 percent of patients with relapsed or refractory multiple ...
Source: Johnson and Johnson - December 10, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

A Rural Hospital ’s Excruciating Choice: $3.2 Million a Year or Inpatient Care?
CASCADE, Idaho — It was 3 a.m. at the 10-bed hospital near the River of No Return, and by every measure, Ella Wenrich should have been dead. Gastrointestinal bleeding had sent her hemoglobin level — typically above 12 — down to 3.3, and she needed an enormous blood transfusion at a larger medical…#stalphonsusneighborhoodhospital #americanhospitalassociation #carriecochranmcclain #kansas #michigan #ouachitacountymedicalcenter #iowa #vietnam #nationalruralhealthassociation #boise (Source: Reuters: Health)
Source: Reuters: Health - December 9, 2022 Category: Consumer Health News Source Type: news